Consultation record

Submissions accepted — page 4

The submission is accepted and the draft is amended as proposed. The amendment is recorded in the amendment log of the document it changed and is traceable to the numbered submission.

Submissions

735 documents · page 4 of 25

Table 1. Submissions with this disposition, on this page.

Reference	Consultation	Respondent	Point raised
DRAFT-ENDOTOXIN-ST/009	Draft standard: bacterial endotoxin testing of peptide presentations	Dr Abimbola Sotomayor-Ekwueme	The standard specifies how to test a unit and not which units to test
DRAFT-ENDOTOXIN-ST/010	Draft standard: bacterial endotoxin testing of peptide presentations	Professor Bartolomeu Nkosi-Lindegaard	Nothing requires the report to state who performed the determination
DRAFT-ENDOTOXIN-ST/011	Draft standard: bacterial endotoxin testing of peptide presentations	Dr Melisande Thorsby-Nakamura	The reporting threshold is not tied to a demonstrated limit of quantitation
DRAFT-ANALYTICAL-S/001	Draft scope of the analytical and methodological standards series	Dr Rosalind Petrossian	A printed copy loses the document identifier
DRAFT-ANALYTICAL-S/002	Draft scope of the analytical and methodological standards series	Dr Hyacinth Drakeford-Amadi	A printed copy loses the information that makes it checkable
DRAFT-ANALYTICAL-S/005	Draft scope of the analytical and methodological standards series	Quentin Whitmarsh-Obi	The registry is published only as pages and not in a form that can be processed
DRAFT-ANALYTICAL-S/006	Draft scope of the analytical and methodological standards series	Yolanda Norrington-Bhatt	A figure carries information that appears nowhere in text
DRAFT-ANALYTICAL-S/007	Draft scope of the analytical and methodological standards series	Thaddeus Isaksen-Balogun	The same quantity is rounded differently in two parts of one document
DRAFT-ANALYTICAL-S/008	Draft scope of the analytical and methodological standards series	Dr Anselm Thorsby-Nakamura	A field the Institute could not verify should be shown rather than omitted
DRAFT-GLP1-OBESITY/001	Draft synthesis: glucagon-like peptide-1 receptor agonists for weight…	Dr Jozef Brandvold-Achterberg	Results at materially different follow-up durations are pooled
DRAFT-GLP1-OBESITY/003	Draft synthesis: glucagon-like peptide-1 receptor agonists for weight…	Dr Evander Ashworth-Danquah	An indirect comparison is presented without an assessment of transitivity
DRAFT-GLP1-OBESITY/004	Draft synthesis: glucagon-like peptide-1 receptor agonists for weight…	Dr Kolawole Isaksen-Balogun	Intention-to-treat and efficacy-estimand results are combined without distinction
DRAFT-GLP1-OBESITY/006	Draft synthesis: glucagon-like peptide-1 receptor agonists for weight…	Dr Odalys Thorsby-Nakamura	Absence of evidence is presented in a form a reader will take as negative evidence
DRAFT-GLP1-OBESITY/010	Draft synthesis: glucagon-like peptide-1 receptor agonists for weight…	Thaddeus Isaksen-Balogun	Overlapping primary studies across included reviews are counted more than once
DRAFT-GLP1-OBESITY/011	Draft synthesis: glucagon-like peptide-1 receptor agonists for weight…	Dr Yusuf Whitmarsh-Obi	Registered trials that never reported are not counted anywhere in the review
DRAFT-GLP1-OBESITY/014	Draft synthesis: glucagon-like peptide-1 receptor agonists for weight…	Dr Theodora Ingelbrecht	Doses differing several-fold are pooled without examining dose-response
DRAFT-LEAN-MASS-SC/003	Draft scoping review: change in lean mass during pharmacologically…	Dr Yaa Kettlewell	Intention-to-treat and efficacy-estimand results are combined without distinction
DRAFT-LEAN-MASS-SC/004	Draft scoping review: change in lean mass during pharmacologically…	Dr Jozef Brandvold-Achterberg	Registered trials that never reported are not counted anywhere in the review
DRAFT-LEAN-MASS-SC/006	Draft scoping review: change in lean mass during pharmacologically…	Dr Oisín Rautavaara	The timepoint at which each outcome was extracted was chosen after the data were seen
DRAFT-LEAN-MASS-SC/007	Draft scoping review: change in lean mass during pharmacologically…	Dr Ndidi Ravensworth-Ilunga	Results at materially different follow-up durations are pooled
DRAFT-GASTROPARESI/002	Draft safety review: delayed gastric emptying and procedural sedation	Dr Vittoria Quintanilha	Attrition is assessed in the risk-of-bias domains and not reported as a number
DRAFT-GASTROPARESI/006	Draft safety review: delayed gastric emptying and procedural sedation	Dr Evander Ashworth-Danquah	The same concept is given three different names in one document
DRAFT-GASTROPARESI/009	Draft safety review: delayed gastric emptying and procedural sedation	Dr Jozef Brandvold-Achterberg	The conclusion is stated more strongly than the certainty rating supports
DRAFT-GASTROPARESI/011	Draft safety review: delayed gastric emptying and procedural sedation	Dr Yusuf Whitmarsh-Obi	Results at materially different follow-up durations are pooled
DRAFT-GASTROPARESI/012	Draft safety review: delayed gastric emptying and procedural sedation	Dr Kolawole Isaksen-Balogun	A single-trial result is presented in the visual form of a pooled estimate
DRAFT-GASTROPARESI/013	Draft safety review: delayed gastric emptying and procedural sedation	Dr Delphine Trelawney	The comparator was given at a dose below the one in general use
DRAFT-GASTROPARESI/014	Draft safety review: delayed gastric emptying and procedural sedation	Thaddeus Isaksen-Balogun	A funnel plot is presented for a set too small to interpret it
DRAFT-GASTROPARESI/015	Draft safety review: delayed gastric emptying and procedural sedation	Dr Oisín Rautavaara	Studies using different outcome definitions are pooled into one estimate
DRAFT-THYROID-C-CE/001	Draft safety review: the rodent thyroid C-cell signal and its human…	Dr Ivo Quintanilha	The conclusion is stated more strongly than the certainty rating supports
DRAFT-THYROID-C-CE/007	Draft safety review: the rodent thyroid C-cell signal and its human…	Dr Yusuf Whitmarsh-Obi	Attrition is assessed in the risk-of-bias domains and not reported as a number

page 4 of 25